These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6527352)

  • 1. Effects of pH and ascorbic acid on 3H-spiperone and 3H-dihydroalprenolol binding in rat forebrain homogenates.
    Bruinink A; Lichtensteiger W
    J Recept Res; 1984; 4(1-6):127-39. PubMed ID: 6527352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbate-induced lipid peroxidation and the binding of [3H]dihydroalprenolol.
    Heikkila RE
    Eur J Pharmacol; 1983 Sep; 93(1-2):79-85. PubMed ID: 6628548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in 3H-spiperone, 3H-WB 4101 and 3H-dihydroalprenolol bindings to brain membranes produced by postnatal pretreatment with chlorpromazine in adult rats.
    Hayashi T; Kunihara M; Tadokoro S
    Jpn J Pharmacol; 1985 Sep; 39(1):45-50. PubMed ID: 2866265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effects of ascorbate on serotonin and spiperone binding in rat cortical membranes.
    Muakkassah-Kelly SF; Andresen JW; Shih JC; Hochstein P
    J Neurochem; 1983 Nov; 41(5):1429-39. PubMed ID: 6413657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of ascorbic acid on the binding of [3H]dopamine antagonists to neostriatal membrane preparations: relationship to lipid peroxidation.
    Heikkila RE; Cabbat FS; Manzino L
    J Neurochem; 1982 Apr; 38(4):1000-6. PubMed ID: 7062025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic localization of peripheral benzodiazepine, dihydroalprenolol and arginine vasopressin binding sites in the pituitaries of control, stalk transected and Brattleboro rats.
    Bunn SJ; Hanley MR; Wilkin GP
    Neuroendocrinology; 1986; 44(1):76-83. PubMed ID: 3785575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbate-induced lipid peroxidation and inhibition of [3H]spiroperidol binding in neostriatal membrane preparations.
    Heikkila RE; Cabbat FS
    J Neurochem; 1983 Nov; 41(5):1384-92. PubMed ID: 6619873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid.
    Bacopoulos NG
    Biochem Pharmacol; 1982 Oct; 31(19):3085-91. PubMed ID: 7150335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased [3H]serotonin and [3H]spiperone binding consequent to lipid peroxidation in rat cortical membranes.
    Muakkassah-Kelly SF; Andresen JW; Shih JC; Hochstein P
    Biochem Biophys Res Commun; 1982 Feb; 104(3):1003-10. PubMed ID: 7073721
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid reduces accumulation of [3H]spiperone in mouse striatum in vivo.
    Dorris RL
    Proc Soc Exp Biol Med; 1987 Oct; 186(1):13-6. PubMed ID: 3628250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H; Wedel I
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical studies of the mesolimbic dopaminergic pathway: [3H]spiperone labels two bindings sites in homogenates of the nucleus accumbens of rat brain.
    Beart PM; McDonald D
    J Neurochem; 1982 Nov; 39(5):1452-60. PubMed ID: 6126526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic proglumide increases [3H]spiperone binding in the rat brain.
    Bean AJ; Baldy WJ; Martin GE
    Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.